The stock is in a strong uptrend, with a 1-year price change of +28.6% and currently trading at 97.1% of its 52-week range ($21.17 vs. $8.82 low and $21.811 high). This positioning near the high end of the range indicates robust momentum and bullish sentiment, though it also suggests the stock may be overextended in the short term. The 52-week low of $8.82 was set in February 2026, and the subsequent recovery has been sharp, with the stock more than doubling from that level. Short-term momentum is accelerating, with a 1-month price change of +24.6% and a 3-month change of +75.2%, far outpacing the S&P 500's 1-month return of 0.6% and 3-month return of 6.3%. This divergence between the stock's strong short-term gains and the broader market's modest performance signals exceptional relative strength, but also raises caution about potential mean reversion. The 1-month relative strength of +24.0% versus the S&P 500 confirms the stock is in a powerful momentum phase. Key support lies at the 52-week low of $8.82, while resistance is at the 52-week high of $21.811. A breakout above $21.811 would signal a continuation of the uptrend, potentially targeting new highs, while a breakdown below $8.82 would indicate a reversal of the recovery. The stock's beta of 1.192 implies it is 19.2% more volatile than the market, meaning it tends to amplify market moves, which is important for risk management.

Revenue is growing strongly, with the most recent quarter (Q1 2026) reporting $385.2 million, up 8.6% year-over-year from $354.6 million in Q1 2025. The multi-quarter trend shows accelerating growth: Q2 2025 revenue was $390.6 million (up from $184.5 million in Q2 2024, a 112% surge due to the Sterling acquisition), and Q3 2025 revenue was $409.2 million. The Sterling segment contributed $190.5 million in Q1 2026, representing 49.5% of total revenue, while First Advantage Americas added $172.3 million (44.7%) and First Advantage International $22.4 million (5.8%). The growth trajectory is robust, driven by the Sterling acquisition and organic expansion, supporting the investment case for continued scale and market share gains. Profitability is improving but remains modest. Net income in Q1 2026 was $2.2 million, up from a loss of $41.2 million in Q1 2025, reflecting a significant turnaround. Gross margin was 29.0% in Q1 2026, down from 45.7% in Q1 2025, likely due to the Sterling acquisition's lower-margin revenue mix. Operating margin improved to 8.8% from 2.1% a year ago, indicating better cost control. The company is now profitable on a net income basis, with a net margin of 0.6%, though still thin. The trajectory toward higher profitability is positive, but margins remain below industry averages for specialty business services. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.59, indicating significant debt. Free cash flow (FCF) was $46.6 million in Q1 2026, up from $19.0 million in Q1 2025, and trailing twelve-month FCF was $218.7 million, providing ample cash generation. The current ratio of 2.44 suggests strong liquidity. Return on equity (ROE) is negative at -2.65% due to negative equity, but this is improving as net income turns positive. The company generates sufficient cash to service debt and fund operations, reducing financial risk.